Back Refine search Reset
Please choose a search criteria from below
Filters Clear all

Best Medical Oncologist in Birmingham, UK

0 results found for Medical Oncologist in Birmingham, UK

Sort by:
We didn't find any results for your search within 15 miles of Birmingham, UK
Here are closest specialists matching your search
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
21 years of experience
Anal Cancer, Bowel Cancer, Breast Cancer, Breast Pain Management + 16 more

Dr Sarah Smith is the Clinical Director for Oncology and Palliative Care at Bedford Hospital and also holds the position as Governance Lead at Addenbrooke's Hospital, in addition to her private practice at GenesisCare Milton Keynes. She specialises in rectal, ovarian and endometrial cancer treatment in Bedford Hospital and has opened multiple nationally-recognised trials for local patient participation; striving to better patient treatment and care.

Dr Smith undertook her initial medical training at Imperial College London, graduating in 1998. Dr Smith also obtained BSc Medical Science at St. Bartholomew's and the Royal London School of Medicine in 1997.

After completing her general medical training, during which time she obtained her MRCP, she went onto the specialist registrar clinical oncology London training programme for five years, working at various London hospitals during this time, including University College Hospital, Mount Vernon Hospital and the Royal Marsden Hospital, and also obtained her FRCR. Dr Smith joined Bedford Hospital NHS Trust in 2008 as a Consultant Clinical Oncologist.

Diseases, Medical Tests and Treatments

  • Breast Pain Management
  • Chemotherapy
  • Clinical Trials
  • Radiotherapy
  • Stereotactic Ablative Radiotherapy (SABR)
  • Stereotactic Radiosurgery (SRS)
  • Video Consultation
  • Image Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Radiotherapy
  • RapidArc Or Volume Modulated Arc Therapy (VMAT)
  • Deep Inspiration Breath Hold
  • Flexible Cystoscopy
  • Palliative Radiotherapy
  • Surface Guided Radiotherapy (SGRT)
  • Anal Cancer
  • Bowel Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Gynaecological Cancers
  • Ovarian Cancer
  • Rectal Cancer
Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Bladder Cancer, Bowel Cancer, Colon Cancer, Colorectal Cancer + 5 more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
GenesisCare Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Recommended by 1 specialist
29 years of experience
Biological Therapy, Bladder Cancer, Chemotherapy, Hormone Therapy + 4 more

Professor. Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. He is a highly experienced Consultant Medical Oncologist specialising in managing urological cancer (prostate, kidney, bladder and testicular cancer) at Oxford since 2001. He qualified from St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds. His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award.  

Professor. Protheroe specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families covering all aspects of chemotherapy, hormonal therapy, immunotherapy, radium 223, growth inhibitors and novel therapies; giving plentiful options to give patients as many options as possible.

In addition to his other work, he is also one of the founding trustees for the urological cancer charity UCARE which supports research and awareness. He was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer.

It is clear from Professor Protheroe's work in both clinical practice, research and charity work that he is fully invested in the clinical care of his patients but also supporting their emotional wellbeing, giving them the best overall experience in their cancer journey.

Diseases, Medical Tests and Treatments
  • Immunotherapy
  • Personalised medicine for urological cancers
  • Gastroesophageal
  • Head and neck oncology
  • Chemotherapy
  • Haemato-oncology
  • Breast ultrasound
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
Read more
Video consultation
Dr Paul Mulholland - Medical Oncologist
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW - 86.50 miles
BMI Bishops Wood Hospital - 86.50 miles
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW
Recommended by 1 specialist
27 years of experience
Brain Cancer, Brain Tumours, Brain Metastasis, Clinical Trials + 3 more

Dr Mulholland is a medical Oncologist who exclusively treats brain cancer at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre.He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.




Diseases, Medical Tests and Treatments

  • Cancer prevention and screening 
  • Chemotherapy 
  • Brain cancer 
  • Neuro-endocrine tumours 
  • Central nervous system cancer 
  • Novel agents 
Read more
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD - 88.47 miles
Spire Bushey Hospital - 88.47 miles
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD
25 years of experience
Adenocarcinoma, Anal Cancer, Bilary Cancer, Bile Duct Cancer (Cholangiocarcinoma) + 41 more

Dr Gaya qualified at St George’s (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London. He was a consultant clinical oncologist at Guy's and St Thomas' Hospitals for 15 years.

Dr Gaya treats all gastrointestinal tumours (e.g. oesophagus, stomach, liver, pancreas, colon, rectum, anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. Dr Gaya’s main interests are in the areas of functional cancer imaging (Kings College, London), and combining immunotherapy with radiation treatment.

He is heavily involved with the implementation and usage of the latest radiotherapy techniques such as MRI guided radiotherapy, proton therapy and stereotactic body radiosurgery (gamma knife, cyberknife). He has published and peer-reviewed widely for international journals.

Offering both drug-based and radiation-based therapies and close liaison with surgical and interventional radiology, he is a leading authority on the unique combination of multiple treatment modalities and personalised tumour molecular profiling into a treatment package for each patient.

Dr Andrew Gaya is a renowned and respected Consultant Oncologist with HCA Healthcare. He helps those with care and compassion at a time when they need it most. His vast experience enables him to provide a first-class service to those suffering from cancer.

In his spare time, he enjoys staying active by diving, tennis and football.

Diseases, Medical Tests and Treatments
  • Chemotherapy
  • External beam radiotherapy (including IMRT and IGRT)
  • Biological and targeted therapies
  • Immunotherapies
  • Stereotactic radiotherapy (SBRT, SABR, Cyberknife)
  • MRI Guided Stereotactic Radiotherapy (MR Linac)
  • Proton therapy
  • SIRT (radioembolisation)
  • Next generation sequencing and molecular analysis of tumours
  • Chemotherapy sensitivity testing
  • Gastrointestinal Cancer
  • Bowel Cancer
  • Rectal Cancer
  • Anal Cancer
  • Liver Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Skin Cancer
  • Cancer of Unknown Primary
Read more
Video consultation
Dr Khurum Hayat Khan - Medical Oncologist
St Johns Wood, London, United Kingdom, NW8 7JA - 98.61 miles
The Wellington Hospital - 98.61 miles
St Johns Wood, London, United Kingdom, NW8 7JA
15 years of experience
Colorectal Cancer, Chemotherapy, Bowel Cancer, Pancreatic Cancer + 24 more

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at

Diseases, Medical Tests and Treatments
  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies
Read more
15-17 Lodge Road, London, United Kingdom, NW8 7JA - 98.62 miles
Platinum Medical Centre - 98.62 miles
15-17 Lodge Road, London, United Kingdom, NW8 7JA
22 years of experience
Lung Cancer, Chemotherapy, Immunotherapy, Biological Therapy + 5 more

Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, especially lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award.


Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals and completed a PhD in tumour immunology. He was appointed to Chelsea & Westminster Hospital in 2010.

Current Roles

Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital, and is Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organistion which supports and educates thoracic oncology profressionals across the United Kingdom. Dr Newsom-Davis is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT), and Chair of the HCA Healthcare UK Thoracic Oncology Board.


Dr Newsom-Davis has an active clinical trial portfolio, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Diseases, Medical Tests and Treatments

  • Immunotherapy, Targeted Therapy, Chemotherapy
  • Lung Cancer
  • Mesothelioma
Read more
Video consultation
Dr Jonathan Shamash - Medical Oncologist
22 Devonshire Place, London, United Kingdom, W1G 6JA - 99.45 miles
The Duchess of Devonshire Wing - 99.45 miles
22 Devonshire Place, London, United Kingdom, W1G 6JA
32 years of experience
Bladder Cancer, Bone Marrow Transplant, Chemotherapy, Clinical Trials + 12 more

Dr Jonathan Shamash is a Consultant Oncologist and is the Lead in Acute Oncology at St Bartholomew’s Hospital and has a further NHS base at Queen’s Hospital, Romford. Dr Shamash also sees patients privately, including at Leaders in Oncology Care. He graduated from the University of Edinburgh in 1987 and then undertook post graduate training in London, gaining an MD in in-vitro modelling of lymphoma.

Dr Shamash sub-specialises in genito-urinary cancers and thoracic malignancies. He has a special interest in managing complex oncology problems and delivering intensive treatments, including high dose Interleukin-2 and high does chemotherapy in testicular cancer. . Dr Shamash also chairs the supra-regional germ cell tumour multidisciplinary meeting and is a member of the NCRI testis clinical studies group. He leads various clinical studies in the management of testicular and prostate cancer and has published widely.

Read more
20 Devonshire Place, London, United Kingdom, W1G 6BW - 99.48 miles
London Clinic - 99.48 miles
20 Devonshire Place, London, United Kingdom, W1G 6BW
15 years of experience
Biological Therapy, Breast Cancer, Chemotherapy, Clinical Trials + 6 more

Dr Amna Sheri is a Consultant Medical Oncologist based in London. She manages all aspects of systemic therapy for early and advanced breast cancer including adjuvant therapy, neo-adjuvant therapy, immunotherapy, treatment of secondary breast cancer, novel biological and targeted therapies and breast cancer in young women.

Dr Sheri graduated from Imperial College London in 2004 and trained in Medical Oncology at the Royal Marsden Hospital. Following this, she was awarded an MD research degree from the Institute of Cancer Research for her work into the prediction of outcome following neo-adjvuant therapy. In 2015, she appointed as a Consultant Medical Oncologist specialising in Breast Cancer and Melanoma at the Royal Free Hospital.

Dr Sheri is actively involved in research particularly on the use of prognostic and predictive biomarkers in early breast cancer. She  has published extensively in peer-reviewed journals and presented her work at both national and international meetings.

Diseases, Medical Tests and Treatments
  • Biological Therapy
  • Chemotherapy
  • Clinical Trials
  • Hormone Therapy
  • Immunotherapy
  • Neoadjuvant
  • Targeted Therapy
  • Breast Cancer
  • Breast Cancer in Young Women
  • Pregnancy Assocaited Breast Cancer
  • Melanoma
Read more
Video consultation
Professor Robert Leonard - Medical Oncologist
Cromwell Road, London, United Kingdom, SW5 0TU - 99.51 miles
Cromwell Hospital - 99.51 miles
Cromwell Road, London, United Kingdom, SW5 0TU
48 years of experience
Bowel Cancer, Breast Cancer, Breast Pain Management, Clinical Trials + 7 more

Professor Leonard trained in London as a where he undertook his initial medical training and training as a senior house officer, he went to Oxford as a registrar and research fellow at Oxford University, Newcastle as a senior registrar and was awarded the Cancer Research Campaign Travelling Fellowship in 1981 to train as a Clinical Fellow at Harvard Medical School and the Dana Farber Cancer Institute in Boston.

Professor Leonard then returned to the UK to take up a senior lectureship and consultant post in Edinburgh where he worked for 19 years helping to start the academic medical oncology department.

In addition to his excellence in practice for which he has won numerous awards, Professor Leonard is also passionate about medical research for which he has been involved in the publishing on over 300 papers on the biology and treatment of cancer, with a strong focus on breast cancer trials.

He was offered the new Chair of Medical Oncology at Swansea University and Chair of the South West Wales Cancer Institute in 2001 and left 5 years later to lead the oncology department at Imperial College NHS Trust as a Professor of Oncology. Professor Leonard retired from the NHS in 2011; now devoting his time to completing trials set up by his Anglo Celtic Collaborative 0ncology Group and to private practice.

Diseases, Medical Tests and Treatments
  • Medical management of cancer
  • Management of breast cancer
  • Breast Cancer
  • Lymphoma
Read more